22M – 1 year on 1mg Finasteride + 5mg Oral Minoxidil, still experiencing diffuse thinning. What are my options? 9/20/2026
A 22-year-old has been using 1mg Finasteride and 5mg oral Minoxidil for a year but still experiences diffuse thinning. Suggestions include checking vitamin levels, switching gradually to oral Dutasteride, and adding microneedling.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 18M Diffuse thinning with 7ng/mL Vit D. Is it just the deficiency or is 0.5mg Fin mandatory?
An 18-year-old with diffuse hair thinning is considering switching from a topical Minoxidil 10% + Finasteride 0.1% solution to Minoxidil 5% foam and oral Finasteride 0.5mg, while also addressing vitamin D deficiency and potential scalp inflammation. Users suggest using Nizoral shampoo for inflammation, considering dutasteride for better results, and maintaining vitamin D levels to protect hair follicles from DHT.
community 18M Diffuse Thinning Progress: 11 Months Oral Minoxidil + 3 Months Vit D3/ K2 (No DHT Blockers)
An 18-year-old shared their hair recovery journey using oral Minoxidil for 11 months and Vitamin D3/K2 for 3 months, without DHT blockers. They are seeking opinions on whether their hair is improving and thickening.
community 2 Year Update: 24 months of Dutasteride 1mg Daily and 2.5-5mg Oral Minoxidil Daily on Diffuse Unpatterned Alopecia
A user experienced significant hair regrowth after 24 months using 1mg daily Dutasteride and 2.5-5mg oral Minoxidil for diffuse unpatterned alopecia. The discussion covers treatment effectiveness, side effects, and comparisons with Finasteride.
community Why is diffuse thinning so hard to recover, 3 plus years on meds!
The user has been using finasteride and minoxidil for over three years, switched to oral minoxidil, and recently started dutasteride and dermarolling but still experiences thin hair. They are seeking suggestions for improving their hair condition.
community 5 months into 0.5mg Dutasteride 3x a week + 5mg Oral Minoxidil
A user is treating hair loss with 0.5mg Dutasteride three times a week, 5mg oral Minoxidil daily, and topical finasteride and minoxidil, seeing some improvement but insufficient density. They are considering increasing Dutasteride dosage and addressing high estradiol levels, while also trying to quit vaping.
Related Research
6 / 6 results
research Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
This review discusses the evaluation and management of male baldness and related conditions, but reports no new clinical results.
research Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
This review discusses recent advancements in understanding the pathophysiology of androgenetic alopecia and highlights the potential for multilateral topical therapies to improve treatment efficacy with fewer side effects; it reports no new clinical results.
research Female pattern hair loss in men: A distinct clinical variant of androgenetic alopecia
This study reported that low-dose oral minoxidil combined with a 5α-reductase inhibitor improved hair density in most men with female pattern hair loss after 6 months or more of treatment.
research Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
This review article reports recent advancements in understanding, diagnosing, and treating various hair loss conditions, like androgenetic alopecia and alopecia areata, including their genetic factors and new therapeutic options, while also examining the impact of COVID-19 on hair loss.
research Androgenetic Alopecia: Therapy Update
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
research Female Androgenetic Alopecia: An Update on Diagnosis and Management
This review discusses female androgenetic alopecia, highlighting its diagnostic challenges and management strategies, but it reports no new results.